|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 | |
| C07D 413/04 | |||
| A61P 27/00 |
| (11) | Patento numeris | 3033332 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14753140.4 |
| Europos patento paraiškos padavimo data | 2014-08-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2014/052511 |
| Data | 2014-08-14 |
| (87) | Numeris | WO 2015/022547 |
| Data | 2015-02-19 |
| (30) | Numeris | Data | Šalis |
| 201314578 | 2013-08-14 | GB | |
| 201361865696 P | 2013-08-14 | US |
| (72) |
EDWARDS, Hannah Joy, GB
EVANS, David Michael, GB
DAVIE, Rebecca Louise, GB
ROOKER, David Philip, GB
HEWISON, Steven John, GB
|
| (73) |
Kalvista Pharmaceuticals Limited,
Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF,
GB
|
| (54) | BICYCLIC PLASMA KALLIKREIN INHIBITORS |
| BICYCLIC PLASMA KALLIKREIN INHIBITORS |